Apple Q4 2024 earnings call: Services revenue drives growth amid mixed
challenges
-
Apple, one of the world’s most valuable companies, continues to impress
with its strong performance. Known for its high levels of customer
satisfaction a...
6 hours ago
CW,
ReplyDeleteInvest to receive panadols to ease the pain of losses?
Eh. Sneaky leh. Under the guise of latest update, you choose to "highlight" the datapoint of 1 to support your case?
Nah! You not like that.
If not you won't show the other 2 out of 3 cases where you wished you have sold in your previous post ;)
Phew! For a moment I was worried I think like the majority.
Walau. The other two no change. 2007 is still historical high. For DBS, new historical high in 2017 as of now.
DeleteWhere got sneaky har?
Hmm, for myself even though have more than recovered from the deep drawdowns of 2008 ... but I think I prefer the *informed* selling or cut loss, to avoid future deep losses.
ReplyDeleteEven though receive panadols, but also many worries lah:
1) Panadol may be cut due to company/industry going thru secular slump OR unable to recover.
2) Dunno how long the headache will last --- 6 months? 1 year? 5 years?
3) Whether headache will progress into stroke .... from polyclinic to ICU?
Hence I've been practicing non-thinking method of sell/buy since 2011. Sometimes performance not as good as buy-and-hold especially in non-trending markets (whip-saws). But I take that as insurance costs. And the avoidance of big pullbacks, while being able to buy back in relatively quickly soon after the lows more than pays for the costs.